Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Statement

15 Oct 2024 07:00

RNS Number : 1270I
Quartix Technologies PLC
15 October 2024
 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Trading Statement

 

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, software and services, is pleased to provide the following trading statement, covering the nine months to 30 September 2024 (the "9m Period").

Recurring revenues, pricing and customer base

Renewed focus on the Company's core business continued to drive strong growth in its Annualised Recurring Revenue ("ARR"). ARR is the key forward-looking measure of growth and financial performance for the Company. The Company's ARR increased by £3.1m (+11%) in the 12 months from 1 October 2023 to 30 September 2024. ARR growth is measured on a constant currency basis, using the rates applicable at 30 September 2024.

During the 9m Period, the Company's ARR grew by £2.7m, an increase of more than 60% on ARR growth achieved for the equivalent period in 2023. (£1.7m)

Average revenue per unit ("ARPU") during the 9m Period decreased by 0.1% on a constant currency basis, representing a significant improvement in performance when compared to the same period in 2023, during which we experienced a decrease of 3.4%. The Company has now implemented an appropriate annual price indexation policy and process for future price revisions and will continue to focus on this key metric.

Attrition as at 30 September (on a trailing 12 months' basis) was 13.8%, showing a slight improvement on performance at the end of H1 (14.0%). Attrition in the 9m Period has reduced in most territories and it also remains an important area of focus.

The key metrics shown below include growth expressed as a % since 1 October 2023, with the exception of the figures given for new subscriptions and new customers, for which the growth shown is for the 9m Period (from 1 January 2024 to 30 September 2024) compared to the same period in 2023.

Renewed focus on customer acquisition drove a 29% increase in this measure in the third quarter compared to Q3 2023, and this improvement is expected to continue.

Country

ARR (£m)

%

Subscription Base (units)

%

Customer Base

%

New Subscriptions (units)

%

New Customers

%

UK/EI

17.49

+5%

154,448

+7%

11,555

+2%

22,980

+14%

1,174

+16%

France

8.05

+18%

77,667

+21%

8,907

+12%

17,341

+4%

1,730

+2%

USA

3.01

+2%

29,268

-1%

3,798

-2%

4,853

-1%

531

-8%

Italy

1.21

+61%

13,412

+59%

2,101

+49%

4,514

+48%

703

+68%

Spain

0.84

+41%

10,669

+46%

1,958

+37%

3,484

+37%

611

+30%

Germany

0.59

+64%

5,972

+58%

893

+45%

2,260

+103%

320

+82%

Other

0.05

590

90

100

3

Total

31.26

+11%

292,026

+13%

29,302

+10%

55,532

+14%

5,072

+16%

 

Market performance

UK

A continued emphasis on the Company's core business has driven a strong increase in customer acquisition and new subscriptions, leading to a 7% increase in the subscription base and 5% growth in ARR. Improvements were made in the management of each of our channels to market.

France

The subscription and customer bases grew by 21% and 12% respectively on a trailing 12-month basis. New subscriptions and customer acquisition were 4% and 2% ahead of the same period last year, respectively, and good progress is now being made through all channels.

USA

In the past few months we have started to rebuild our sales and support capacity for the USA, effectively reversing the organisational and strategic changes made during 2022 and 2023. Attrition also reduced and, in the past three months, the customer and subscription bases returned to modest growth. As a consequence, the Company achieved growth in ARR in the first 9 months of $0.1m versus a deficit of $0.2m last year. Enquiry levels are good and customer acquisition rates in the third quarter were more than double the rate for Q3 2023.

Italy, Spain and Germany

The company recorded strong growth on all key performance measures in each of these countries. New customer acquisition rates in Italy were particularly strong, as was growth in new installations in Germany. All three countries offer substantial opportunities for business development and we will make further investment in the remainder of the year and in 2025.

Financial results for the Period

The Board is confident of meeting market expectations for the year1 for both profit and free cashflow. The Company's net cash balance at period-end (30 September 2024) was £2.3m, following payment of an Interim Dividend of 1.5p per share and the final contracted purchase payment to shareholders of Konetik Deutschland GmbH ("Konetik"); both of which were made during September. Liquidation of Konetik is now largely complete, and anticipated costs of closure were provided for in the Company's Interim Results. The anticipated divergence between free cashflow and EBITDA in 2024 is a result of the Company's committed programme of equipment upgrades in France and the investment in growth in the subscription base.

More than 40% of the Company's revenue is derived from the EU and USA, and continuing growth in the strength of the pound has therefore had a marginal impact on the Board's previous estimates of revenue for the year. This, as noted above, is not expected to affect profit or cash generation.

Andy Walters, Executive Chairman of Quartix, commented:

"The rate of growth in the Company's recurring revenues, customer base and new subscriptions over the period is very pleasing. I am immensely grateful to all my colleagues and the management team at Quartix who have so successfully refocused the company on its core business activity since my return to the Board a year ago, and we look forward to the future with confidence."

1Note: the Company believes that, prior to this announcement, market expectations for 2024 performance in terms of revenue, adjusted EBITDA and unadjusted free cashflow were £32.9m, £5.8m and £2.1m respectively.

For further information contact:

Andy Walters, Executive Chairman.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMMGVDLGDZM
Date   Source Headline
27th May 20214:25 pmRNSExercise of Share Options, PDMR Shareholding & TVR
25th May 20217:56 amRNSGranting of Options
21st May 20217:00 amRNSDirectorate Changes and Trading Update
26th Mar 20211:57 pmRNSExercise of Options, Director/PDMR Dealing & TVR
23rd Mar 20212:56 pmRNSResult of AGM
23rd Mar 20217:00 amRNSAGM Trading Statement
12th Mar 20211:34 pmRNSExercise of Options, Director/PDMR Dealing & TVR
4th Mar 20211:57 pmRNSExercise of share options and Total Voting Rights
3rd Mar 20217:00 amRNSDividend Timetable and Correction of Record Date
1st Mar 20217:00 amRNSFinal Results
20th Jan 202111:24 amRNSHolding(s) in Company
19th Jan 202111:24 amRNSResult of Secondary Placing
19th Jan 20217:00 amRNSProposed Secondary Placing
11th Jan 20217:00 amRNSTrading Statement
8th Jan 20215:15 pmRNSHolding(s) in Company
6th Jan 20213:11 pmRNSHolding(s) in Company
15th Dec 20204:40 pmRNSSecond Price Monitoring Extn
15th Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Oct 20207:00 amRNSTrading Statement
24th Sep 20207:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20207:00 amRNSInterim Results
17th Jul 20207:00 amRNSNotice of Interim Results
2nd Jun 20207:00 amRNSTrading Statement
27th Apr 20207:00 amRNSTrading Statement
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20201:10 pmRNSResult of AGM
24th Mar 202012:35 pmRNSExercise of Options and Issue of Equity
24th Mar 20207:00 amRNSAGM Trading Statement
19th Mar 20207:00 amRNSMeasures taken re Coronavirus and Dividend
9th Mar 20203:47 pmRNSPDMR Share Transfer
24th Feb 20207:00 amRNSFinal Results
13th Jan 20207:00 amRNSTrading Statement
23rd Oct 20197:00 amRNSDirectorate Changes
24th Jul 20197:00 amRNSInterim Results
19th Jun 20197:00 amRNSTrading Update
14th May 20198:58 amRNSDirector/PDMR Shareholding
10th May 20195:52 pmRNSHolding(s) in Company
15th Apr 201912:32 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSSenior Appointments
28th Mar 20198:43 amRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSAGM Trading Statement
5th Mar 20197:00 amRNSHolding(s) in Company
25th Feb 20197:00 amRNSFinal Results
22nd Feb 20197:00 amRNSChange of Registered Office
30th Jan 20199:11 amRNSHolding(s) in Company
10th Jan 20197:00 amRNSTrading Statement
5th Dec 20187:00 amRNSExercise and Granting of Options
4th Dec 20187:00 amRNSTrading Statement
4th Oct 20187:00 amRNSBoard Update
13th Aug 20184:12 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.